Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-10-18
2005-10-18
Krass, Frederick (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S297000, C514S970000, C424S489000, C424S490000, C424S493000, C424S494000, C424S497000, C424S499000, C424S501000
Reexamination Certificate
active
06956043
ABSTRACT:
A pharmaceutical composition in the form of a solid dispersion comprising a macrolide, e.g. a rapamycin or an ascomycin, and a carrier medium.
REFERENCES:
patent: 3852421 (1974-12-01), Koyanagi et al.
patent: 3929992 (1975-12-01), Sehgal et al.
patent: 4248856 (1981-02-01), Guley et al.
patent: 4309404 (1982-01-01), DeNeale et al.
patent: 4309405 (1982-01-01), Guley et al.
patent: 4415547 (1983-11-01), Yu et al.
patent: 4421738 (1983-12-01), Yamagiwa et al.
patent: 4650666 (1987-03-01), Izutsu et al.
patent: 4753801 (1988-06-01), Oren et al.
patent: 4916138 (1990-04-01), Ueda et al.
patent: 5026560 (1991-06-01), Makino et al.
patent: 5078999 (1992-01-01), Warner et al.
patent: 5100883 (1992-03-01), Schiehser
patent: 5100899 (1992-03-01), Caine
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5260301 (1993-11-01), Nakanishi et al.
patent: 5286730 (1994-02-01), Caufield et al.
patent: 5352671 (1994-10-01), Baumann et al.
patent: 5352783 (1994-10-01), Shafiee et al.
patent: 5384130 (1995-01-01), Kamada
patent: 5387589 (1995-02-01), Kulkarni
patent: 5456923 (1995-10-01), Nakamichi et al.
patent: 5457111 (1995-10-01), Luly et al.
patent: 5457194 (1995-10-01), Luly et al.
patent: 5472954 (1995-12-01), Loftsson
patent: 5514686 (1996-05-01), Mochizuki et al.
patent: 5516770 (1996-05-01), Waranis et al.
patent: 5530006 (1996-06-01), Waranis et al.
patent: 5536729 (1996-07-01), Waranis et al.
patent: 5547948 (1996-08-01), Barcomb
patent: 5559121 (1996-09-01), Harrison et al.
patent: 5616588 (1997-04-01), Waranis et al.
patent: 5616595 (1997-04-01), Chu et al.
patent: 5665772 (1997-09-01), Cottens et al.
patent: 5686110 (1997-11-01), Greenwald et al.
patent: 5691334 (1997-11-01), Doria et al.
patent: 5725883 (1998-03-01), Staniforth et al.
patent: 5759576 (1998-06-01), Barcomb
patent: 5759577 (1998-06-01), Barcomb
patent: 5766623 (1998-06-01), Ayres et al.
patent: 5776495 (1998-07-01), Duclos et al.
patent: 5780062 (1998-07-01), Frank et al.
patent: 5817333 (1998-10-01), Kagayama et al.
patent: 5932243 (1999-08-01), Fricker et al.
patent: 5985325 (1999-11-01), Nagi
patent: 5989591 (1999-11-01), Nagi
patent: 6004973 (1999-12-01), Guitard et al.
patent: 6262127 (2001-07-01), Acemoglu et al.
patent: 2164100 (1995-01-01), None
patent: 2170748 (1995-03-01), None
patent: 44 18 115 (1994-12-01), None
patent: 43 22 826 (1995-01-01), None
patent: 43 29 503 (1995-03-01), None
patent: 041 795 (1981-12-01), None
patent: 240 773 (1987-10-01), None
patent: 9240773 (1987-10-01), None
patent: 393 575 (1990-10-01), None
patent: 427 680 (1991-05-01), None
patent: 507 555 (1992-10-01), None
patent: 525 960 (1993-02-01), None
patent: 533 433 (1993-03-01), None
patent: 586 310 (1993-11-01), None
patent: 648 494 (1995-04-01), None
patent: 649 659 (1995-04-01), None
patent: 350 730 (1995-05-01), None
patent: 722 720 (1996-07-01), None
patent: 2 722 984 (1996-02-01), None
patent: 2278780 (1994-12-01), None
patent: 2279006 (1994-12-01), None
patent: 03-240726 (1991-10-01), None
patent: WO 91/16882 (1991-11-01), None
patent: WO 92/00739 (1992-01-01), None
patent: WO 92/02229 (1992-02-01), None
patent: WO 93/19763 (1993-10-01), None
patent: WO 96/14833 (1996-05-01), None
patent: WO 96/24332 (1996-08-01), None
patent: WO 96/25150 (1996-08-01), None
patent: WO 96/41807 (1996-12-01), None
patent: WO 97/02017 (1997-01-01), None
patent: WO 97/03654 (1997-02-01), None
Chiou et al., “Pharmaceutical Applications of Solid Dispersion Systems,” J. Pharm. Sci., vol. 60, No. 9, pp. 1281-1302 (1971).
Ford, “The Current Status of Solid Dispersions,” pharm. Acta. Helv., vol. 61, No. 3, pp. 68-88 (1986).
Approved Drug Products, 20th Edition, Prescription Drug Product List, pp. 3-311 (2000).
Derwent Abstract 96-335278 (EP722 720, Jul. 24, 1996).
Hahn et al., “Solid Surfactant Solutions of Active Ingredients in Sugar Esters,” Pharm. Res., vol. 6, No. 11, pp. 958-960 (1989).
Serajuddin, “Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs,” J. Pharm. Sci., vol. 88, No. 10, pp. 1058-1066 (1999).
“Remington's Pharmaceutical Sciences,” Fifteenth Edition, pp. 1422-1423, Mack Publishing Co. (1975).
“Remington's Pharmaceutical Sciences,” Fourteenth Edition, p. 1588 (1975).
Derwent Abstract 94-033829/04 (TW 207954-A, Jun. 21, 1993).
Guitard Patrice
Haeberlin Barbara
Link Rainer
Richter Friedrich
Hess Susan
Krass Frederick
Novartis AG
Wilusz, Jr. E. Jay
LandOfFree
Pharmaceutical compositions comprising... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical compositions comprising..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3449769